A recent study showed that EGFR expression in a GBM xenograft model increased the efficacy of an anti-vascular endothelial growth factor (VEGF) (vandetanib or cediranib) therapy in combination with irradiation when compared to xenografts lacking EGFR expression [40]. This evidence concerns the gene EGFR and glioblastoma.